therapy outcomes
Recently Published Documents


TOTAL DOCUMENTS

1134
(FIVE YEARS 209)

H-INDEX

40
(FIVE YEARS 5)

2022 ◽  
Vol 12 ◽  
Author(s):  
Elena Sacilotto ◽  
Gerardo Salvato ◽  
Federica Villa ◽  
Fulvia Salvi ◽  
Gabriella Bottini

Background: Cinematherapy and video treatments are artistic therapeutic techniques by which the individuals are exposed to their psycho-physical difficulties through the stories of the characters on the screen who are coping with the same issues that the patients are. Although these techniques are increasingly common within modern art therapies, there are neither comprehensive classifications of the different approaches nor agreement on their effectiveness. We performed a scoping review, describing different methodological approaches and outcome measures in cinematherapy and video treatments.Methodology: We searched articles in PubMed, PsycINFO and Google Scholar. We included: (i) articles in which subjects were treated for their difficulties with videos or films, (ii) articles written in English. Review articles and papers describing a research protocol without data collection were not included.Results: We analyzed 38 studies. Thirty-six reported a positive effect of the treatment. Seven studies used classical cinematherapy, adopting a qualitative approach to measure the therapy outcome. Thirty-one studies used different video treatments, 8 of which were defined as randomized controlled trials with specific objective therapy outcomes. Studies were mainly focused on behavioral and psychological difficulties in Autism Spectrum Disorders and Schizophrenia.Conclusion: Studies using video treatments more often rely upon structured experimental designs; on the contrary, those who used classical cinematherapy produced descriptive results. A more standardized methodological approach in terms of experimental design, procedure, and objective outcome measure is needed to provide evidence on the effectiveness of these techniques, promoting its application in the clinical field.


2022 ◽  
pp. 251-277
Author(s):  
Georgios Agathokleous ◽  
Abigail Olubola Taiwo

This chapter covers the broad range of online counselling work, using the COVID-19 era as a point of reference. It provides an overview of online applications of counselling and psychotherapy at pre-COVID-19 time and informs the reader of how online counselling provision has been accelerated during the pandemic. A theoretical overview of the key counselling and therapeutic processes as conceptualised in the cyberspace which considers six distinct modes of online communication are provided. An evaluation and the review of the latest efficacy and effectiveness research evidence of online counselling is also provided. The key benefits and challenges of digitalised therapeutic interventions from the clients' and therapists' perspectives covering pre and during COVID-19 are identified. Attention is drawn to existing studies on counselling engagement, adherence, outreach, non-stigmatising counselling practices, power imbalances in the counselling process, and therapy outcomes.


2021 ◽  
Vol 8 ◽  
Author(s):  
Juan Jovel ◽  
Russell Greiner

Machine learning (ML) approaches are a collection of algorithms that attempt to extract patterns from data and to associate such patterns with discrete classes of samples in the data—e.g., given a series of features describing persons, a ML model predicts whether a person is diseased or healthy, or given features of animals, it predicts weather an animal is treated or control, or whether molecules have the potential to interact or not, etc. ML approaches can also find such patterns in an agnostic manner, i.e., without having information about the classes. Respectively, those methods are referred to as supervised and unsupervised ML. A third type of ML is reinforcement learning, which attempts to find a sequence of actions that contribute to achieving a specific goal. All of these methods are becoming increasingly popular in biomedical research in quite diverse areas including drug design, stratification of patients, medical images analysis, molecular interactions, prediction of therapy outcomes and many more. We describe several supervised and unsupervised ML techniques, and illustrate a series of prototypical examples using state-of-the-art computational approaches. Given the complexity of reinforcement learning, it is not discussed in detail here, instead, interested readers are referred to excellent reviews on that topic. We focus on concepts rather than procedures, as our goal is to attract the attention of researchers in biomedicine toward the plethora of powerful ML methods and their potential to leverage basic and applied research programs.


2021 ◽  
Vol 50 (1) ◽  
pp. 579-579
Author(s):  
Lece Webb ◽  
Rouba Chahine ◽  
Inmaculada Aban ◽  
Priya Prabhakaran ◽  
Jeremy Loberger

2021 ◽  
Vol In Press (In Press) ◽  
Author(s):  
Seyed Ahmad Rasoulinejad

Background: Diabetic retinopathy (DR) is a visual impairment-related eye disease developed by long-term hyperglycemic status. Diabetic condition in DR patients leads to diabetic organopathies (e.g., renal failure). Albuminuria, as a hallmark of renal failure, can be correlated with visual indicators in DR patients. Objectives: This study aimed to investigate the role of albuminuria status in visual acuity (VA) and bevacizumab therapy outcomes in DR patients. Methods: In this retrospective study, 48 DR patients were admitted to the Ophthalmology Center of Ayatollah Rouhani Hospital, affiliated with Babol University of Medical Sciences, Babol, Iran. The retinopathy status and VA were identified before and after treatment through 45 days of bevacizumab therapy. In addition, fast blood sugar, hemoglobin A1c, urine albumin, and urine creatinine were evaluated using standard laboratory methods. Results: The VA value before treatment in microalbuminuric DR patients (0.106 ± 0.036) was significantly lower than non-microalbuminuric DR patients (0.347 ± 0.286; P < 0.001). Furthermore, VA value after treatment in microalbuminuric DR patients (0.115 ± 0.071) was significantly lower than non-microalbuminuric DR patients (0.355 ± 0.272; P < 0.001). There was no significant difference in the percentage of VA increase between microalbuminuric and non-microalbuminuric patients. Moreover, the albumin-to-creatinine ratio (ACR) was correlated with a lower VA level before and after treatment (P < 0.001 for both). There was no correlation between the percentage of VA increase with ACR, albumin, and creatinine. Conclusions: The current study results showed that different VA before and after bevacizumab therapy status was correlated with microalbuminuria status. Additionally, microalbuminuria status did not affect the percentage of VA increase in the treatment of DR patients.


Retina ◽  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Javier Zarranz-Ventura ◽  
Vuong Nguyen ◽  
Catherine Creuzot-Garcher ◽  
Frank Verbraak ◽  
Louise O´Toole ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document